Biotech · Private company
Curevo Inc
Track this companyFree. Adds Curevo Inc to your Dealase workspace and tells you when its record changes.
Clinical trials21 recruiting or active
Pipeline programs7From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline7
- Amezosvatein Adjuvant Dose Arm DPhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- Amezosvatein Adjuvant Dose Arm FPhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- Amezosvatein Adjuvant Dose Arm HPhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- Amezosvatein Antigen High Dose Arm APhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- Amezosvatein Antigen Low Dose Arm BPhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- ShingrixPhase 2 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
- CRV 101Phase 1 · Herpes ZosterClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and OlderPHASE2 · ACTIVE_NOT_RECRUITING · started Feb 2, 2022ClinicalTrials.gov NCT05304351 · fetched Nov 12, 2026
- Safety, Tolerability, and Immunogenicity of CRV-101 in Healthy Adult SubjectsPHASE1 · COMPLETED · started Jan 3, 2019ClinicalTrials.gov NCT03820414 · fetched Nov 12, 2026